SABCS Future Focus

Latest SABCS Future Focus News

Questions Remain on ADC Sequencing in Metastatic Breast Cancer

Promising findings from various clinical trials at the San Antonio Breast Cancer

Derick Alison Derick Alison

PD-L1 Subgroup Benefits Most From Neoadjuvant Immunotherapy in Early Breast Cancer

Promising findings from two clinical trials at the San Antonio Breast Cancer

Derick Alison Derick Alison

Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer

The investigational Trop2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) continued to demonstrate

Derick Alison Derick Alison

SABCS 2023 Highlights Open the Door for More Key Data in 2024

In this exclusive MedPage Today video, Virginia Kaklamani, MD, DSc, of UT

Derick Alison Derick Alison
adbanner